Cancer peptide vaccine therapy for patients with advanced metastatic colorectal cancer. Phase I/II clinical trial.
Phase 1
- Conditions
- Colorectal cancer
- Registration Number
- JPRN-UMIN000004945
- Lead Sponsor
- Tokai University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1 Cardiac diseases necessitating treatments 2 Myocardial infarction less than 6 months 3 Expectant or possible expectant women During lactation 4 Active infectious diseases 5 Systemic use of steroid hormones or immunosuppressive drugs 6 Allergy to peptides or IFA 7 Others (Doctors judges)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety Responsiveness (tumor size)
- Secondary Outcome Measures
Name Time Method Immunological response (in vitro CTL induction)